Novo Nordisk said on Monday it is offering its diabetes drug Ozempic for $499 per month to eligible cash-paying type 2 ...

We live in a world where $1 billion of prescription medications are left at the pharmacy counter each year, often because ...

Prescription savings platform GoodRx is collaborating with pharma giant Novo Nordisk to make Ozempic and Wegovy pens ...

Moderately bullish activity in Hims and Hers Health (HIMS), with shares down $1.36 near $43.21. Options volume relatively light with 86k contracts ...

Hims & Hers investors hit with more bad news as Novo Nordisk partners with GoodRx to offer discounted access to competing products. ETFs with high concentration in HIMS may face risks and losses.